Recent studies indicated AURKA is associated with resistance to EGFR inhibitors in EGFR-mutant LUAD 25, and increased AURKA expression is associated with poor prognosis of NSCLC patients 26. Here, EGFR is linked to non-small cell lung carcinoma.